The progression of a tumor cell from one of benign delimited prolifera
tion to invasive and metastatic growth is the major cause of poor clin
ical outcome of cancer patients. Recent research has revealed that thi
s complex process requires many components for successful disseminatio
n and growth of the tumor cell at secondary sites. These include angio
genesis, enhanced extracellular matrix degradation via tumor and host-
secreted proteases, tumor cell migration, and modulation of tumor cell
adhesion. Each individual component is multifaceted and is discussed
within this review with respect to historical and recent findings. The
identification of components and their interrelationship have yielded
new therapeutic targets leading to the development of agents that may
prove effective in the treatment of cancer and its metastatic progres
sion.